Skip to main content

Assessment of ARIA Sufficiency: Jesduvroq (daprodustat)

    Basic Details
    Approval Date
    Wednesday, February 1, 2023
    Original Posting Date
    Health Outcome(s)
    adverse pregnancy and fetal outcomes
    drug induced liver injury
    gastrointestinal (GI) bleed
    heart failure
    major adverse cardiovascular events
    malignancy
    retinopathy proliferative
    venous thromboembolism (VTE)